The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage

Acta Neurochir Suppl. 2011;110(Pt 1):203-8. doi: 10.1007/978-3-7091-0353-1_35.

Abstract

Background: It is hypothesized that inflammatory response after subarachnoid hemorrhage (SAH) may play a relevant role in the development and maintenance of vasospasm. This research investigated the correlation between IL-6 in cerebrospinal fluid (CSF) after SAH and the occurrence of vasospasm.

Methods: We analyzed both daily clinical manifestation and laboratory data of CSF in 46 patients who suffered from intracranial aneurismal subarachnoid hemorrhage during a period of 14 days, studied the relationship between the development of vasospasm and the quantities of the inflammatory factor, revealing potential power of IL-6 for predicting vasospasm detected by transcranial doppler (TCD).

Results: The incidence of vasospasm developed in 43.5% of the patients, with a mean onset of 6.1±4.6 days after intracranial aneurysm treatment. Patients with vasospasm demonstrated statistically significant higher median values of IL-6CSF on Day 1, 2, 3, 5 and 7 (P<0.05). The cut-off value is settled in 400 pg/ml on Day 3 after treatment. On the other hand, gender, Hunt & Hess scale (H&H) and Fisher scale of CT after SAH were proved to be the correlation factor with vasospasm.

Conclusion: IL-6CSF seems to be a reliable early marker for predicting vasospasm after subarachnoid hemorrhage on Days 3 after treatment before clinical onset.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Interleukin-6 / cerebrospinal fluid*
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • ROC Curve
  • Subarachnoid Hemorrhage / cerebrospinal fluid
  • Subarachnoid Hemorrhage / complications*
  • Time Factors
  • Ultrasonography, Doppler, Transcranial / methods
  • Vasospasm, Intracranial / cerebrospinal fluid*
  • Vasospasm, Intracranial / diagnostic imaging
  • Vasospasm, Intracranial / etiology*

Substances

  • Interleukin-6